US Broker Ratings

United Therapeutics Corporation (UTHR) Stock Analysis: A Potential 34% Upside in the Healthcare Sector

United Therapeutics Corporation (NASDAQ: UTHR), a key player in the healthcare sector, presents an intriguing opportunity for investors. With a market capitalization of $12.82 billion, the company specializes in the..

DaVita Inc. (DVA) Stock Report: Exploring a 12.34% Potential Upside for Healthcare Investors

DaVita Inc. (NYSE: DVA), a prominent player in the healthcare sector, specifically within the medical care facilities industry, is drawing attention from investors with its significant market capitalization of $10.71..

Align Technology, Inc. (ALGN) Stock Analysis: Exploring a 23% Upside Potential Amidst Market Challenges

Align Technology, Inc. (NASDAQ: ALGN), a leader in the healthcare sector specializing in medical instruments and supplies, presents an intriguing investment narrative with its current stock price at $188.52 and..

Fresenius Medical Care AG (FMS): Investor Outlook on a Global Dialysis Leader with 12% Upside Potential

Fresenius Medical Care AG (NYSE: FMS) stands at the forefront of the healthcare sector, specializing in dialysis and related services for individuals with renal diseases. With a market capitalization of..

Bristol-Myers Squibb (BMY) Stock Analysis: Unlocking a 23% Upside Potential

Bristol-Myers Squibb Company (BMY), a heavyweight in the healthcare sector, is a titan of the drug manufacturing industry with a market capitalization of $94.33 billion. As an investor, understanding BMY’s..

Agilent Technologies, Inc. (A): Investor Outlook and 14.55% Upside Potential

Agilent Technologies, Inc. (NYSE: A) stands as a prominent player in the healthcare sector, particularly within the diagnostics and research industry. With a market cap of $33.85 billion, Agilent has..

Humana Inc. (HUM) Stock Analysis: Navigating Potential Upside Amid Industry Challenges

Humana Inc. (NYSE: HUM), a prominent player in the healthcare plans industry, is currently positioned at an intriguing juncture for investors seeking both stability and potential upside. With a market..

Summit Therapeutics Inc. (SMMT): Investor Outlook on a 71% Potential Upside in the Biotech Sector

Summit Therapeutics Inc. (NASDAQ: SMMT), a prominent player in the biotechnology sector, is making waves in the financial markets with its significant potential upside. The company, with a current market..

Amgen Inc. (AMGN) Stock Analysis: A 13.4% Potential Upside with Robust Dividend Yield

For individual investors seeking both growth and income, Amgen Inc. (NASDAQ: AMGN) presents a compelling picture. Positioned within the healthcare sector, Amgen is a leader in drug manufacturing with a..

Boston Scientific Corporation (BSX) Stock Analysis: A Strong Buy with 10.34% Potential Upside

Boston Scientific Corporation (NYSE: BSX), a heavyweight in the healthcare sector with a market cap of $157.61 billion, continues to capture the attention of investors with its robust market presence..

Veeva Systems Inc. (VEEV) Stock Analysis: Exploring a 2.91% Upside with Robust Revenue Growth

For investors seeking exposure in the healthcare technology space, Veeva Systems Inc. (NYSE: VEEV) presents an intriguing opportunity. With a market capitalization of $46.31 billion and a strong presence in..

BeOne Medicines Ltd. (ONC) Stock Analysis: A Promising 37% Upside Potential in the Biotech Sector

BeOne Medicines Ltd. (ONC), a Switzerland-based biotechnology company, is making significant strides in the healthcare sector, particularly in oncology. With a market capitalization of $28.04 billion and a diverse portfolio..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Exploring a 20% Upside Potential in the Healthcare Sector

IQVIA Holdings, Inc. (NYSE: IQV), a formidable player in the healthcare sector, particularly in diagnostics and research, is presenting an intriguing opportunity for investors. With a market capitalization of $27.24..

Hologic, Inc. (HOLX) Stock Analysis: Assessing a Healthcare Pioneer with 3.48% Potential Upside

Hologic, Inc. (NASDAQ: HOLX), a prominent player in the healthcare sector with a solid foothold in medical instruments and supplies, is gaining investor attention as analysts forecast a potential upside..

BioMarin Pharmaceutical (BMRN) Stock Analysis: Unveiling a 73.65% Potential Upside

For investors seeking promising opportunities within the biotechnology sector, BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) presents an intriguing case. With a market capitalization of $10.58 billion, BioMarin stands as a key..

The Cooper Companies, Inc. (COO) Stock Analysis: Exploring a 30.76% Potential Upside

The Cooper Companies, Inc. (NYSE: COO), a prominent player in the healthcare sector, is capturing attention with its notable potential upside of 30.76%. With a market capitalization of $14.19 billion,..

AptarGroup, Inc. (ATR) Stock Analysis: A Closer Look at Its 12.31% Potential Upside

In the competitive sector of healthcare, AptarGroup, Inc. (NYSE: ATR) stands out as a key player in the medical instruments and supplies industry. With a market capitalization of $10.29 billion,..

Novo Nordisk A/S (NVO) Stock Analysis: Strong Growth and Impressive 35% Upside Potential

Novo Nordisk A/S (NYSE: NVO), a titan in the healthcare sector with a market capitalization of $304.6 billion, has been catching the eyes of investors, particularly given its substantial potential..

Tempus AI, Inc. (TEM) Stock Analysis: Navigating Growth with a 75% Revenue Surge Amidst Market Volatility

Tempus AI, Inc. (NASDAQ: TEM) is making waves in the healthcare technology sector, attracting significant attention with its impressive revenue growth of 75.40%. This Chicago-based company, specializing in advanced healthcare..

West Pharmaceutical Services, Inc. (WST) Stock Analysis: Uncovering a 27.40% Potential Upside

West Pharmaceutical Services, Inc. (NYSE: WST) stands as a notable player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $15.72 billion,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds